Thomas Hirose, MD
Pathologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis Testicular Mesothelioma
Cancer Antigen 125, CA Fibulin-3 Human MPF ELISA Kit Mesomark Osteopontin SOMAmer Panel
Dr. Thomas Hirose graduated the medical school from the David Geffen at UCLA. He did his internship at the University of California Irvine and completed two residency programs: one at the Cedar-Sinai Medical Center and the Beth Israel Deaconess Medical Center. He is specialized in pathology and board certified in anatomic pathology & clinical pathology. Dr. Hirose has been in practice for more than 20 years and is affiliated with the Good Samaritan Hospital. During his career, he has also contributed to 1 publication of medical interest.
David Geffen at UCLA
Medical School
University of California Irvine
Internship
Cedars-Sinai Medical Center
Residency
Beth Israel Deaconess Medical Center
Residency
American Board of Pathology
The safety of RhIG in the prevention of haemolytic disease of the newborn.
Hirose, T. G.,Mays, D. A.; J Obstet Gynaecol. 2007 Sep 27.
See more >>